rs397507466
|
|
Cardio-facio-cutaneous syndrome
|
G |
0.810 |
GeneticVariation
|
CLINVAR |
We speculate that the impact of p.L245F on BRAF protein function differs either qualitatively or quantitatively from those mutations associated with CFCS.
|
19416762 |
2009 |
rs397507466
|
|
Cardio-facio-cutaneous syndrome
|
A |
0.810 |
GeneticVariation
|
CLINVAR |
Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrum.
|
19206169 |
2009 |
rs397507466
|
|
Cardio-facio-cutaneous syndrome
|
G |
0.810 |
GeneticVariation
|
CLINVAR |
Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrum.
|
19206169 |
2009 |
rs397507466
|
|
Cardio-facio-cutaneous syndrome
|
A |
0.810 |
GeneticVariation
|
CLINVAR |
We speculate that the impact of p.L245F on BRAF protein function differs either qualitatively or quantitatively from those mutations associated with CFCS.
|
19416762 |
2009 |
rs180177042
|
|
Cardio-facio-cutaneous syndrome
|
T |
0.800 |
GeneticVariation
|
CLINVAR |
|
|
|
rs121913377
|
|
melanoma
|
TT |
0.800 |
GeneticVariation
|
CLINVAR |
Phase II trial (BREAK-2) of the BRAF inhibitor dabrafenib (GSK2118436) in patients with metastatic melanoma.
|
23918947 |
2013 |
rs121913377
|
|
melanoma
|
TT |
0.800 |
GeneticVariation
|
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
rs121913377
|
|
melanoma
|
TT |
0.800 |
GeneticVariation
|
CLINVAR |
Overwhelming response to Dabrafenib in a patient with double BRAF mutation (V600E; V600M) metastatic malignant melanoma.
|
23031422 |
2012 |
rs121913377
|
|
melanoma
|
TT |
0.800 |
GeneticVariation
|
CLINVAR |
Vemurafenib produced improved rates of overall and progression-free survival in patients with previously untreated melanoma with the BRAF V600E mutation.
|
21639808 |
2011 |
rs121913377
|
|
melanoma
|
TT |
0.800 |
GeneticVariation
|
CLINVAR |
Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study.
|
24508103 |
2014 |
rs121913351
|
|
melanoma
|
G |
0.800 |
GeneticVariation
|
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
rs121913351
|
|
melanoma
|
T |
0.800 |
GeneticVariation
|
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
rs121913351
|
|
melanoma
|
T |
0.800 |
GeneticVariation
|
CLINVAR |
Frequency and spectrum of BRAF mutations in a retrospective, single-institution study of 1112 cases of melanoma.
|
23273605 |
2013 |
rs121913341
|
|
Cardio-facio-cutaneous syndrome
|
C |
0.800 |
GeneticVariation
|
CLINVAR |
Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome.
|
16439621 |
2006 |
rs121913341
|
|
Cardio-facio-cutaneous syndrome
|
C |
0.800 |
GeneticVariation
|
CLINVAR |
Mutation and phenotypic spectrum in patients with cardio-facio-cutaneous and Costello syndrome.
|
18042262 |
2008 |
rs121913341
|
|
Cardio-facio-cutaneous syndrome
|
C |
0.800 |
GeneticVariation
|
CLINVAR |
A structural systems biology approach for quantifying the systemic consequences of missense mutations in proteins.
|
23093928 |
2012 |
rs113488022
|
|
Brain Neoplasms
|
T |
0.800 |
GeneticVariation
|
CLINVAR |
Targeted therapy for BRAFV600E malignant astrocytoma.
|
22038996 |
2011 |
rs113488022
|
|
Brain Neoplasms
|
T |
0.800 |
GeneticVariation
|
CLINVAR |
Cooperative interactions of BRAFV600E kinase and CDKN2A locus deficiency in pediatric malignant astrocytoma as a basis for rational therapy.
|
22586120 |
2012 |
rs113488022
|
|
Adenocarcinoma of lung (disorder)
|
T |
0.800 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs113488022
|
|
Glioblastoma
|
T |
0.800 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs113488022
|
|
Cutaneous Melanoma
|
T |
0.800 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs113488022
|
|
melanoma
|
G |
0.800 |
GeneticVariation
|
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
rs113488022
|
|
Brain Neoplasms
|
T |
0.800 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs113488022
|
|
Neoplasms
|
T |
0.800 |
GeneticVariation
|
CLINVAR |
Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF.
|
15035987 |
2004 |
rs121913364
|
|
Neoplasms
|
C |
0.780 |
GeneticVariation
|
CLINVAR |
Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF.
|
15035987 |
2004 |